Studies have shown that AMP-activated protein kinase (AMPK), a crucial regulator of energy homeostasis, plays important roles in osteoblast differentiation and mineralization. However, little is known about in vivo roles of osteoblastic AMPK in bone development. Thus, to investigate in vivo roles of osteoblast AMPK, we conditionally inactivated Ampk in osterix (Osx)-expressing cells by crossing Osx-Cre mice with floxed AMPKa1 to generate mice lacking AMPKa1 in osteoblasts (Ampk 2/2 mice). Compared with wild-type and Ampk +/2 mice, Ampk 2/2 mice displayed retardation of postnatal bone development, although bone deformity was not observed at birth. Microcomputed tomography showed significant reductions in trabecular bone volume, cortical bone length, and density, as well as increased cortical porosity in femur as well as development defects of skull in 8-week-old Ampk 2/2 mice. Surprisingly, histomorphometric analysis demonstrated that the number of osteoclasts was significantly increased, although bone formation rate was not altered. Loss of trabecular network connections and mass, as well as shortened growth plates and reduced thickness of cartilage adjacent to the growth plate, was observed in Ampk 2/2 mice. In primary cultured osteoblasts from calvaria, the expressions of alkaline phosphatase, type 1 collagen, osteocalcin, bone morphogenetic protein 2, Runx2, and osterix were significantly inhibited in Ampk 2/2 osteoblasts, whereas the expression of receptor activator of nuclear kB ligand (RANKL) and the RANKL/osteoprotegerin ratio were significantly increased. These findings indicate that osteoblastic AMPK plays important roles in bone development in vivo and that deletion of AMPK in osteoblasts decreases osteoblastic differentiation and enhances bone turnover by increasing RANKL expression. (Endocrinology 159: 597-608, 2018) A MP-activated protein kinase (AMPK) is a crucial regulator of energy and metabolic homeostasis at the cellular and whole-organism levels (1, 2). AMPK is found in single-cell eukaryotes, such as the yeast Saccharomyces cerevisiae and the primitive protist Giardia lamblia, and considered a metabolic stress-sensing enzyme that plays key roles in regulating cellular and wholebody energy homeostasis (3). It is a highly conserved serine/threonine heterotrimeric protein, consisting of a catalytic a subunit and two regulatory b and g subunits, and functions as a serine/threonine kinase. An increase in the cellular AMP/adenosine triphosphate ratio activates AMPK through the phosphorylation of the a subunit.
the expression of bone morphogenetic protein 2 (BMP-2) and endothelial nitric oxide synthase via inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase (9) (10) (11) . Moreover, other researchers reported that AMPK activation induced calcified nodule formation in primary osteoblasts, whereas AMPK inhibition suppressed the effects of AMPK and osteoblastic differentiation (12, 13) . These findings suggest that AMPK has an important function in the differentiation of osteoblasts and bone formation.
On the other hand, previous studies have shown that AMPK activation directly inhibits osteoclastogenesis (14, 15) . Furthermore, it is reported that AMPK activation indirectly suppresses osteoclast differentiation by stimulating osteoprotegerin (OPG) and reducing receptor activator of nuclear kB ligand (RANKL) expression in osteoblasts (16) . In addition, we recently showed that AMPK activation significantly decreased RANKL expression in osteocytic MLO-Y4 cells and that knockdown of AMPKa1 significantly increased RANKL expression (8) . These findings suggest that AMPK activation inhibits osteoclast activity directly and indirectly by decreasing RANKL expression in both osteoblasts and osteocytes. Thus, AMPK may play a pivotal role in osteoclastogenesis and bone remodeling.
Recently, a few studies using genetic mutant mice have shown that inactivation of AMPK decreases bone mass in vivo (7, 12, 17) . Shah et al. (12) generated conventional AMPKa1 knockout mice and examined the bone phenotype by microcomputed tomography (mCT). Both cortical and trabecular bone compartments were significantly smaller in AMPKa1 knockout mice compared with the WT littermates. Moreover, dynamic bone histomorphometric analysis showed increased bone turnover and bone resorption in the knockout mice compared with that of their WT littermates (17) . Taken together, these findings suggest that AMPK may play important roles in bone development and remodeling. However, AMPK acts as a crucial regulator of whole-body energy and metabolic homeostasis (1, 2) , which may affect bone metabolism. In addition, AMPK in osteocytes and osteoclasts may play important roles in bone development. Therefore, the roles of AMPK in osteoblasts are still unclear. In this study, to investigate in vivo roles of osteoblast AMPK, we conditionally inactivated AMPK by crossing osterix (Osx)-Cre mice with floxed AMPKa1 (Ampk flox/flox ) to generate mice lacking AMPKa1 in osteoblasts (Ampk 2/2 mice).
Materials and Methods

Generation of knockout mice
A conditional knockout mouse model, in which the Ampka1 gene is deleted specifically in osteoblasts, was generated. ); both were on the C57BL/6J background. All mice, which were used in this study, were male. Mice were maintained in a pathogenfree standard animal facility, and experimental procedures were performed following an animal use protocol approved by the Animal Care and Use Committee of Shimane University Faculty of Medicine.
The genotypes of Ampk 2/2 and control mice were confirmed by reverse transcription-polymerase chain reaction (RT-PCR). The PCR conditions were as follows: 28 cycles of denaturation at 95°C for 15 seconds, annealing at 60°C for 15 seconds, and elongation at 72°C for 30 seconds. This was performed on genomic DNA extracted from mouse tails using a proteinase K digestion kit (KAPA Biosystems, Woburn, MA) as previously described (20) . Genotyping was conducted using primers described by the Jackson Laboratory to detect the AMPK floxed allele (forward 5 0 -CCCACCATCACTCCATCTCT-3 0 and reverse 5 0 -AGCCTGCTTGGCACACTTAT-3 0 ) and the Osx-Cre transgenes (forward 5 0 -GCGGTCTGGCAGTAAAAACTATC-3 0 and reverse 5 0 -GTGAAACAGCATTGCTGTCACTT-3 0 ). To test for the specific deletion of Ampka1 exon 3, genomic DNA isolated from different tissues was amplified using a combination of primers: A (5 0 -CCCACCATCACTCCATCTC-3 0 ), B (5 0 -AGCCTGCTTGGCACACTTAT-3 0 ), and C (5 0 -ATTAAG-GGTGAGCACAGACCAG-3 0 ). PCR of the recombinant D3 Ampk allele generates a 395-bp amplicon (primers A + C), and the Ampk flox allele generates a 296-bp amplicon (primers A + B).
mCT analysis
Mouse femurs and skulls, dissected free of soft tissue, were fixed in 70% ethanol. High-resolution images were acquired with a microfocus X-ray CT system (Scan Xmate-L090; Comscantecno Co., Ltd., Yokohama, Japan). The X-ray source was set at 75 kV and 100 mA, and the samples were rotated 360°. Image resolution was fixed at a pixel size of 10.334 mm. The magnification was 9.677 and slice thickness was 10.334 mm. Three-dimensional measurements and structural analyses were performed with custom software (TRI/3D-BON; Ratoc System Engineering, Kanagawa, Japan).
Bone histomorphometric analysis
Mouse femurs were dissected, fixed for 24 hours in 4% formalin, dehydrated in a graded ethanol series, and embedded in methyl methacrylate resin; 3-mm sections were made. After staining with Von Kossa and toluidine blue, histomorphometric analyses were performed with a Histometry RT Camera (System Supply Co., Ltd., Nagano, Japan). For hematoxylin and eosin and Safranin O stainings, decalcified femurs were embedded in paraffin and cut into 5-mm sections. The sections were stained using standard procedures. Images were taken at room temperature using a light microscope (BX53; Olympus, Tokyo, Japan) and examined under natural and polarized light and by fluorescence microscopy. Area of growth plate and mean width of cartilage adjacent to the growth plate were measured by using ImageJ (National Institutes of Health, Bethesda, MD).
Double calcein labeling
Calcein (Sigma, St. Louis, MO) was dissolved in buffer (0.15 M NaCl, 2% NaHCO 3 ) and injected twice intraperitoneally (25 mg/g body weight) at 5 and 2 days before the mice were euthanized (20) . Bones were harvested and embedded in plastic as described above. Serial sections were cut, and the freshly cut surface of each section was viewed and imaged using fluorescence microscopy. The double calcein-labeled width was measured, and the mineral apposition rate (interlabel width/ labeling period) and bone formation rate (BFR)/bone surface were calculated. Calculations were made on a minimum of duplicate specimens from replicate mice in each group.
Osteoblast isolation from mouse calvaria
Osteoblasts from calvaria of individual 1-week-old Ampk 2/2 pups or their WT littermates were isolated as previously described (20) . The bones were dissected free of sutures and subjected to two consecutive digestions at 37°C with shaking in a minimum essential medium (aMEM; Gibco-BRL, Rockville, MD) containing 0.1 mg/mL collagenase P (Roche Applied Science, Penzberg, Germany) and 0.25% trypsin/0.1% EDTA (Invitrogen, San Diego, CA). The supernatant was discarded, leaving the pieces of bone. Fresh digestion medium containing 0.2 mg collagenase P/mL was added, and calvaria were incubated at 37°C with vigorous shaking every 15 minutes for 45 minutes or until bone pieces began to fall apart. The bone pieces and cells were collected by centrifugation (1500 3 g), washed with aMEM, and plated in a 10-cm dish with aMEM containing 10% fetal bovine serum and 1% penicillin/ streptomycin (Invitrogen). On the following day, images were taken at room temperature using a light microscope (TS100; Nikon, Tokyo, Japan). After 4 days, the medium was changed, and when the cells reached 80% confluency, they were passaged to six-well plates (10 5 cells/well).
Bone marrow stromal cell isolation
Bone marrow stromal cells (BMSCs) from femurs of 8-weekold Ampk 2/2 mice or their control littermates were isolated. The mouse femurs were dissected free of surrounding soft tissue. The bone marrow was flushed with aMEM. After centrifuge (1000 rpm for 5 minutes) to isolate the cells from the extra soft tissue, the cells were plated in culture flasks with aMEM containing 10% fetal bovine serum and 1% penicillin/streptomycin, and nonadherent cells were removed. The cell culture medium was replaced every 3 days, and the cells were seeded in six-well plates and cultured in 5% CO 2 at 37°C.
RT-PCR analysis to identify AMPK subunits
To investigate the messenger RNA (mRNA) expression of AMPK subunits (a1 and a2) in primary osteoblasts, we performed RT-PCR. Total RNA was extracted from the cultured cells using Trizol reagent (Invitrogen) according to the manufacturer's recommended protocol. We used 2 mg total RNA for the synthesis of single-stranded complementary DNA (cDNA synthesis kit; Invitrogen, San Diego, CA). The following primers , and black boxes indicate Ampk 2/2 mice. BV, bone volume; SMI, structure model index; TbN, trabecular number; TBPf, trabecular bone pattern factor; TbSp, trabecular separation; TbTh, trabecular thickness; TV, tissue volume. *P , 0.05, **P , 0.01. were used: Ampka1 forward, 5ʹ-CTCTATGCTTTGCTG-TGTGG-3ʹ and Ampka1 reverse, 5ʹ-GGTCCTGGTGGTTT-CTGTTG-3ʹ; Ampka2 forward, 5ʹ-ACAGCGCCATGCA-TATTCCT-3ʹ and Ampka2 reverse, 5ʹ-TCCGACTGTC-TACCAGGTAA-3ʹ. The PCR conditions were as follows: 35 cycles of denaturation at 95°C for 45 seconds, annealing at 60°C for 30 seconds, and elongation at 72°C for 1 minute. The PCR products were separated by electrophoresis on a 1.8% agarose gel and were visualized using ethidium bromide staining with UV light using an electronic ultraviolet transilluminator (Toyobo Co. Ltd., Tokyo, Japan).
Quantification of gene expression by real-time PCR
SYBR green chemistry was used to determine mRNA expression levels. Primers were used as previously described (8) (9) (10) (11) . Real-time PCR was performed in a 25-mL reaction mixture containing 1 mL complementary DNA using an ABI PRISM 7000 (Applied Biosystems, Waltham, MA). Doublestranded DNA-specific SYBR Green I was mixed with the PCR buffer provided in the SYBR Green Real-Time PCR Master Mix (Toyobo Co. Ltd.) to quantify the PCR products. PCR conditions were as follows: initial denaturation at 95°C for 15 minutes and 40 cycles of denaturation at 94°C for 15 seconds and annealing and extension at 60°C for 1 minute. The mRNA level of 36B4, a housekeeping gene, was used to normalize the differences in the efficiency of RT.
Statistical analysis
Results are expressed as mean 6 standard error. Statistical differences between groups were determined using one-way analysis of variance followed by Fisher protected least significant difference. For all statistical tests, a P value of ,0.05 was considered statistically significant. , and black boxes indicate Ampk 2/2 mice. Av, all bone volume; Cntr. L, center line length; Ct, mean cortical bone thickness; Cv, cortical bone volume; Vv, vessel volume. *P , 0.05, **P , 0.01, ***P , 0.001. 1A ) and 2 weeks (Fig. 1B) . The mice then developed dwarfism, characterized by smaller body size and shorter limbs (Fig. 1D) . Body weight of Ampk 2/2 mice at 8 weeks was significantly decreased by 25% compared with that of WT and Ampk +/2 mice (Fig. 1C) . Moreover, femur length and size of Ampk 2/2 mice were reduced compared with those of WT at 8 weeks (Fig. 1E and 1F) . Although serum levels of calcium, phosphorus, albumin, creatinine, and parathyroid hormone (PTH) were measured and compared between Ampk 2/2 and WT mice at 8 weeks, no differences in these levels were observed ( Table 1) . Specificity of Ampk knockout in bone tissue of Ampk 2/2 mice was confirmed by PCR amplification of tissue genomic DNA (Fig. 1G) . To examine the efficiency of Ampka1 knockout in osteoblasts, we performed quantification of Ampka1 expression in isolated primary osteoblasts from calvaria and BMSCs from femur ( Fig. 1H) . Almost 80% and 60% deletion in osteoblasts and BMSCs, respectively, was confirmed. These findings indicate that osteoblast AMPK is required for postnatal bone growth.
Results
Growth retardation of
Osteoblast-specific disruption of the Ampka1 gene decreases bone mass and volume Ampk 2/2 mice had marked reductions in trabecular bone compared with WT and Ampk +/2 mice, assessed by mCT ( Fig. 2A) . Trabecular bone volume/tissue volume was significantly reduced in Ampk 2/2 mice (Fig. 2B) , and trabecular separation and structure model index were significantly increased ( Fig. 2E and 2G) . Moreover, mCT images showed that the cortical bone size was remarkably reduced in Ampk 2/2 mice (Fig. 3A) . Center line length of cortical bone and bone density were significantly decreased in Ampk 2/2 mice (Fig. 3B and 3E ), whereas vessel volume and vessel volume/cortical bone volume were significantly increased ( Fig. 3F and 3G ). In addition, mCT images of skulls showed that smaller and thinner skulls were observed in Ampk 2/2 mice compared with WT and Ampk +/2 mice (Fig. 4A) . Quantification of volume, surface area, and thickness of interparietal bone indicated that skull formation was reduced in Ampk 2/2 mice compared with WT and Ampk +/2 mice ( Fig. 4B-4D ). Representative pictures of toluidine blue staining showed the marked reduction in trabecular bone compared with WT mice (Fig. 5A and 5B). Histomorphometric analysis indicated trabecular bone volume, thickness, and number were significantly reduced in Ampk 2/2 mice compared with those of WT ( Fig. 5C-5E ).
Osteoblast number was slightly increased in Ampk
mice compared with those of WT, although the difference did not reach significance. Mineral apposition rate and BFR showed no difference between Ampk 2/2 mice and WT ( Fig. 5J-5L ). However, BFR was significantly decreased at the endosteal surface of cortical bone in Figure 4 . Developmental defects in skull in Ampk 2/2 mice by mCT. (Fig. 5M) , whereas it was significantly increased at the periosteal surface (Fig. 5N) . In contrast, osteoclast number and osteoclast surface/bone surface increased significantly in Ampk 2/2 mice ( Fig. 5M and 5N ).
Hematoxylin and eosin and Safranin O staining showed the loss of trabecular network connections and mass, as well as shortened growth plates at the femoral distal end, in Ampk 2/2 mice (Fig. 6E-6G ) compared with those of WT (Fig. 6A-6C ). Quantification of growth plate area indicated a significant reduction in Ampk
mice compared with that of WT (Fig. 6I) . The thickness of cartilage adjacent to the growth plates was reduced in Ampk 2/2 mice (Fig. 6H ) compared with that of WT (Fig. 6D) . Quantification of mean width of cartilage adjacent to the growth plate indicated a significant reduction in Ampk 2/2 mice compared with that of WT (Fig. 6J) . These findings suggest the occurrence of delayed epiphyseal ossification.
Disruption of the Ampka1 gene inhibited osteoblastic differentiation and increased RANKL expression
Microscopic images showed that spindle-shaped osteoblast-like cells migrated from collagenase-treated https://academic.oup.com/endocalvaria of WT mice (Fig. 7A) , whereas round-shaped cells were observed from calvaria of Ampk 2/2 mice (Fig. 7B) ,
suggesting that migrated cells from WT mice differentiated to mature osteoblasts, but differentiation of the cells from Ampk 2/2 was inhibited. RT-PCR confirmed that the Ampka1 gene was knocked out in isolated osteoblasts from Ampk osb 2/2 mice (Fig. 7C) . Real-time PCR showed that expressions of Alkaline phosphatase (Alp), Type 1 collagen (T1c), Osteocalcin, Bmp-2, Runx2, and Osterix were significantly suppressed in Ampk 2/2 osteoblasts compared with that of the controls (Fig. 7D-7I ). In contrast, the expressions of Rankl and Rankl/Opg ratio were significantly increased ( Fig. 7J and 7L ). Furthermore, we isolated BMSCs from femurs and examined the expressions of differentiation markers of osteoblasts. Real-time PCR showed that the expressions of Osteocalcin and Bmp-2 were significantly suppressed in Ampk 2/2 BMSCs compared with those of the controls (Fig. 8C and 8D ).
The expressions of Alp, T1c, and Runx2 tended to be decreased in Ampk 2/2 BMSCs (Fig. 8A, 8B , and 8E), whereas Rankl and Rankl/Opg ratio tended to be increased ( Fig. 8G and 8I ), although the differences did not reach significance. These findings indicate that disruption of Ampka1 inhibits the differentiation of osteoblasts and induces osteoclastogenesis by increasing RANKL expression.
Discussion
In the current study, we demonstrated that deletion of AMPKa1 in Osx-lineage cells impaired growth and bone development after birth and decreased trabecular and cortical bone volume. These findings indicate that osteoblast AMPK plays an important role in postnatal bone development. We and other researchers have previously shown that activation of AMPK stimulates the differentiation of osteoblasts (9-13), and in the current study, we found that osteoblastic differentiation was significantly inhibited in primary cultured osteoblasts from Ampk 2/2 mice. We thus hypothesized that the decreased bone volume of Ampk 2/2 mice may be caused by inhibition of bone formation. Because histomorphometric analysis showed a slight increase in the number of osteoblasts and no change in bone formation rate, osteoblast function might be attenuated by deletion of AMPK in osteoblasts. When the BFR was examined at the endosteal and periosteal surface of cortical bone separately, BFR at the endosteal surface was significantly decreased, whereas BFR at the periosteal surface was significantly increased. These findings suggest that deletion of osteoblast AMPK induced the suppression of osteoblast function and epiphyseal ossification, although osteoblasts at the periosteal surface reciprocally activated. In contrast, the number of osteoclasts was significantly increased in Ampk 2/2 mice. Taken together, these findings suggest that osteoblastic AMPK plays important roles in bone formation as well as bone turnover in vivo.
A previous study showed that conventional knockout of AMPKa1 in mice decreased trabecular bone volume in vivo (12, 17) . In these mice, a significant increase in bone resorption was found by histomorphometric analysis. The bone phenotype of AMPKa1 knockout mice is similar to that of our Ampk 2/2 mice. Moreover, previous in vitro studies showed that activation of AMPK significantly decreased the expression of RANKL in osteoblasts (16) . In the current study, we demonstrated that deletion of AMPKa1 significantly increased the expression of Rankl and the ratio of Rankl/Opg in primary cultured osteoblasts from Ampk 2/2 mice compared with that of controls. Therefore, our present findings are consistent with previous studies suggesting that osteoblast AMPK plays an important role in the regulation of osteoclastogenesis and bone turnover by decreasing RANKL expression. In contrast, BFR was slightly, but not significantly, increased in the conventional AMPKa1 knockout mice (17) . Because the current study showed no change in total BFR in our osteoblast-specific AMPKa1 knockout mice, it is suggested that AMPK in other cells might affect bone formation. We previously demonstrated that AMPK activation in osteocytes increased the expression of sclerostin (8), which inhibits osteoblast differentiation (21) . This may explain the difference in BFR between conventional AMPKa1 knockout and ours. Further studies are thus necessary to investigate in vivo roles of osteocyte AMPK in bone. It has been reported that several cytokines and drugs influence AMPK activation and regulate energy homeostasis. Insulinlike growth factor I (IGF-I) is known to be involved in bone formation and remodeling, and it is reported that IGF-I modulates AMPK activity in various cell types (22) . A recent study demonstrated that AMPK activation is required for the activation of IGF-I in early stages of osteoblast differentiation (23) . Moreover, Wang et al. (24) reported that IGF-I receptor knockout mice generated by crossing Osx-Cre transgenic mice showed postnatal bone growth retardation. Osteoblast-specific IGF-I receptor null mice showed irregular morphology of the growth plate and lower trabecular bone volume, accompanied by decreased chondrocyte proliferation and differentiation, as well as decreased osteoblast differentiation; this bone phenotype is similar to that of our AMPK is considered a major target molecule for diabetes mellitus, and diabetes-related osteoporosis has become an important issue worldwide. Although the pathophysiology of diabetes-related bone fragility is still unclear, previous studies suggested that dysfunction of osteoblasts and low turnover of bone are involved (25) . We previously showed that metformin, an antidiabetic drug, stimulates the differentiation and mineralization of osteoblastic MC3T3-E1 cells by activating AMPK (10) . In addition, other researchers have demonstrated that metformin inhibits RANKL expression and stimulates osteoprotegerin expression in osteoblasts; supernatants from cultured osteoblasts treated with metformin significantly suppressed osteoclast formation and expression of tartrate-resistant acid phosphatase and cathepsin K in osteoclasts (16) , leading to an increase in bone mass. Indeed, several clinical studies suggested the beneficial effects of metformin on fracture risk in patients with type 2 diabetes mellitus (26, 27) . Thus, the results of this study may be understood to show the role of AMPK as the target molecule of metformin in bone and suggest that AMPK activation may be a candidate for the treatment of diabetes-related osteoporosis.
Here, we examined the role of AMPK in osteoblast differentiation and bone development. However, previous in vitro studies have shown that AMPK plays a pivotal role in the commitment of multipotential mesenchymal stem cells to osteoblast lineage and adipocytes (28) (29) (30) . Recently, Wang et al. (28, 29) demonstrated that AMPK hyperactivation induced by a lentivirus vector significantly stimulated osteoblastic MC3T3-E1 cell osteogenesis and inhibited 3T3-L1 cell adipogenesis. Chen et al. (30) showed that AMPK activation by metformin activated the osteogenic transcription factor Runx2 and inactivated peroxisome proliferator-activated receptor g, a master regulator of fat cell development. The current study showed that deletion of AMPK in Osx-expressing cells significantly decreased the expression of Runx2 and Osx, although osteoblast number and bone formation were not affected. Because Runx2 and Osx are reported to counteract peroxisome proliferator-activated receptor g-mediated adipogenesis (31, 32) , it would be interesting to examine the effect of AMPK deletion in Osx-expressing cells on bone marrow adiposity in the future.
In conclusion, the current study showed that deletion of osteoblast AMPK induced retardation of postnatal bone development, as well as reduction in trabecular and cortical bone volume, by decreasing osteoblast differentiation and increasing RANKL expression. These findings suggest that osteoblast AMPK plays important roles in bone modeling and remodeling. Accordingly, activation of osteoblast AMPK may be a candidate for treatment of osteoporosis with high bone turnover, as well as diabetes-related osteoporosis, although further studies are necessary to clarify the roles of AMPK in bone.
